New research highlights the potential of the novel diagnostic tool iFRET to determine immunotherapy outcomes in stage 2 ...

Read about Great Western Hospital's sustainability initiatives that led to its recognition as an exemplar organisation by NHS ...

Device-based remote monitoring decreases hospital service use by 72% when used to monitor patients requiring ongoing care.

Switching from beta-blockers to digoxin as first line therapy for older patients with AF could produce £100m in NHS savings annually.

Professor Martin Röcken discusses challenges and opportunities in dermatology care, immunotherapy, the MDT and his hopes for ...

Speaking at Hospital Healthcare Europe’s Clinical Excellence in Cardiovascular Care event, Dr Rebecca Dobson discussed the acute need to assess cardiovascular risk in cancer care, understanding ...